The COVID-19 pandemic raised public awareness of health risks, boosting demand for quality healthcare. With patients becoming more informed and engaged in their health decisions, the need for personalized care has grown, contributing to a thriving healthcare sector. Additionally, increased public investment in healthcare infrastructure enhances the sector's promising outlook.
Therefore, investors might consider investing in fundamentally strong healthcare stocks like Eli Lilly and Company (LLY), Merck & Co., Inc. (MRK), and Abbott Laboratories (ABT), which can thrive in any economy.
